Merck Other Current Assets 2010-2024 | MRK

Merck other current assets for the quarter ending September 30, 2024 were $8.143B, a 22.34% increase year-over-year.

  • Merck other current assets for 2023 were $8.368B, a 16.72% increase from 2022.
  • Merck other current assets for 2022 were $7.169B, a 2.6% increase from 2021.
  • Merck other current assets for 2021 were $6.987B, a 49.49% increase from 2020.

Merck Other Current Assets 2010-2024 | MRK

  • Merck other current assets for 2023 were $8.368B, a 16.72% increase from 2022.
  • Merck other current assets for 2022 were $7.169B, a 2.6% increase from 2021.
  • Merck other current assets for 2021 were $6.987B, a 49.49% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$789.4B
Novo Nordisk (NVO)$481.1B
Johnson & Johnson (JNJ)$374.3B
AbbVie (ABBV)$352.5B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Pfizer (PFE)$151.4B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B